These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27822925)

  • 21. Structured override reasons for drug-drug interaction alerts in electronic health records.
    Wright A; McEvoy DS; Aaron S; McCoy AB; Amato MG; Kim H; Ai A; Cimino JJ; Desai BR; El-Kareh R; Galanter W; Longhurst CA; Malhotra S; Radecki RP; Samal L; Schreiber R; Shelov E; Sirajuddin AM; Sittig DF
    J Am Med Inform Assoc; 2019 Oct; 26(10):934-942. PubMed ID: 31329891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approach.
    Missiakos O; Baysari MT; Day RO
    Int J Med Inform; 2015 Aug; 84(8):595-600. PubMed ID: 25912258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients.
    Wasylewicz ATM; van de Burgt BWM; Manten T; Kerskes M; Compagner WN; Korsten EHM; Egberts TCG; Grouls RJE
    Clin Pharmacol Ther; 2022 Aug; 112(2):382-390. PubMed ID: 35486411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an on-demand drug-drug interaction checker by prescribers and consultants: a retrospective analysis in a Swiss teaching hospital.
    Beeler PE; Eschmann E; Rosen C; Blaser J
    Drug Saf; 2013 Jun; 36(6):427-34. PubMed ID: 23516005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the introduction of a nationwide DUR system where local DUR systems are operating--The Korean experience.
    Yang JH; Kim M; Park YT; Lee EK; Jung CY; Kim S
    Int J Med Inform; 2015 Nov; 84(11):912-9. PubMed ID: 26363001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.
    Seidling HM; Klein U; Schaier M; Czock D; Theile D; Pruszydlo MG; Kaltschmidt J; Mikus G; Haefeli WE
    Int J Med Inform; 2014 Apr; 83(4):285-91. PubMed ID: 24484781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency and nature of drug-drug interactions in a Swiss primary and secondary acute care hospital.
    Oertle M
    Swiss Med Wkly; 2012; 142():w13522. PubMed ID: 22327947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
    Dechanont S; Maphanta S; Butthum B; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semi-Supervised Learning Algorithm for Identifying High-Priority Drug-Drug Interactions Through Adverse Event Reports.
    Liu N; Chen CB; Kumara S
    IEEE J Biomed Health Inform; 2020 Jan; 24(1):57-68. PubMed ID: 31395567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
    J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of provider characteristics on the responses to medication-related decision support alerts.
    Cho I; Slight SP; Nanji KC; Seger DL; Maniam N; Fiskio JM; Dykes PC; Bates DW
    Int J Med Inform; 2015 Sep; 84(9):630-9. PubMed ID: 26004341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants.
    Yeh ML; Chang YJ; Yeh SJ; Huang LJ; Yen YT; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2014; 113(1):15-22. PubMed ID: 24209715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals.
    Antoon JW; Hall M; Herndon A; Carroll A; Ngo ML; Freundlich KL; Stassun JC; Frost P; Johnson DP; Chokshi SB; Brown CM; Browning WL; Feinstein JA; Grijalva CG; Williams DJ
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33037121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overrides of clinical decision support alerts in primary care clinics.
    Slight SP; Nanji KC; Seger DL; Cho I; Volk LA; Bates DW
    Stud Health Technol Inform; 2013; 192():923. PubMed ID: 23920697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential drug-drug interactions within Veterans Affairs medical centers.
    Mahmood M; Malone DC; Skrepnek GH; Abarca J; Armstrong EP; Murphy JE; Grizzle AJ; Ko Y; Woosley RL
    Am J Health Syst Pharm; 2007 Jul; 64(14):1500-5. PubMed ID: 17617500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.